MOESM1 of Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms

Additional file 1. Flowchart of follow-up of patients included in this study. Patients with PSP, DLB and CBS were not selected for the study because of low numbers. Patients with another or uncertain diagnosis were also not selected. VaP and VaP/PD patients were included in the statistical analysis but data is not shown because of the low number of patients in these groups. PD: Parkinson’s disease; MSA: multiple system atrophy; PSP: progressive supranuclear palsy; DLB: dementia with Lewy bodies; VaP: vascular parkinsonism; CBS: corticobasal syndrome; PD/VaP: PD with overlapping VaP. In brackets the number of patients per group. The black squares represent the patients the study focused on.